Ep 190 [01 October 2025]: Jeff Morgan and Karla Feghali – RWE & GenAI: Insights from Deloitte’s 2025 Survey

Ep 190 [01 October 2025]: Deloitte's Jeff Morgan and Karla Feghali – We discussed the history of RWE in our venacular and we unpacked the highlights of Deloitte’s 2025 Real-World Evidence (RWE) Benchmarking Survey. In this conversation, we’ll explored: > How are pharma leaders modernizing their RWE capabilities to support the enterprise? > What role is generative AI really playing in reshaping evidence generation — and where are the biggest hurdles? > Which capabilities and partnerships are setting top performers apart? > What’s next: How will patient-centric approaches, expanding data ecosystems, and evolving regulation shape the future of RWE? You can review the full survey here in advance: https://www.deloitte.com/content/dam/assets-zone3/us/en/docs/services/consulting/2025/ada-compliant-2025-rwe-benchmarking-report.pdf Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.club Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.